Its medicine is also being discovered in India for the treatment of epidemic corona. The Council for Scientific and Industrial Research (CSIR) has received approval from the Drug Controller General of India (DGCI) for clinical trials of two drugs - favipirvir and phytopharmaceutical - to compete with Covid-19.

What is Government Vande Bharat Mission?

Favipirvir drug is commonly used in the treatment of influenza in Japan, China and some other countries. CSIR is exploring biological drugs as phytopharmaceutical, which have already been found successful in treating dengue. Now its effect is being investigated against Covid-19.

Video: Snake enters inside ATM machine in Ghaziabad

In his statement, CSIR Director General Shekhar Mande said that he would start clinical trials of these drugs within a week. He said that CSIR is working with many well-known pharmaceutical companies. He is trying to see if it can bring a definitive solution against the Covid-19. In this regard, clinical trials have been started with some companies last night.

More than three thousand corona patients found everyday, know matter of relief